N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B
US9895349B2 · kind B2 · utility
3Cited by
73References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2014 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Apr 2, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/107
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Inhibitors of HBV replication of Formula (I)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein X, R1, R2, R3 and R4 have the meaning as defined herein.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.